Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism CTSK inhibitors(Cathepsin K inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H30N6O2S |
InChIKeyFIVYCSWOCXEWSE-UHFFFAOYSA-N |
CAS Registry294623-49-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoporosis | Preclinical | US | 01 Dec 2005 |